1. ^*Institut National de la Santé et de la Recherche Médicale (INSERM) U503, Lyon Cedex, France
2. ^†Department of Clinical Immunology and Allergy, Pierre Benite, France
3. ^‡Laboratoires Bioderma, Lyon Cedex, France
4. ^§INSERM U404, Lyon Cedex, France

Correspondence: Jean-Francois Nicolas, Institut National de la Santé et de la Recherche Médicale (INSERM) U503, IFR 128 BioSciences Lyon-Gerland, 21 avenue Tony Garnier, 69375 Lyon Cedex 7, France. Email: nicolas@cervi-lyon.inserm.fr

Received 15 January 2004; Revised 10 August 2004; Accepted 21 September 2004.

Abstract

Mice deficient in the CD4 molecule (CD4- /- ) are widely used to evaluate the requirement for CD4+ T cell help in viral, tumoral, and transplantation immunity. Previous studies, showing that CD4- /- mice develop impaired contact hypersensitivity (CHS) responses, have suggested that CD4+ T cells are required for the optimal induction of this skin inflammatory reaction. other studies have, however, demonstrated that CHS was mediated by CD8+ T cells, without the need for CD4+ T cell help. Here, we show that CD4- /- mice develop a normal delayed-type hypersensitivity response to protein antigen, which is mediated by major histocompatibility molecules class II-restricted CD4- CD8- T cells, but a decreased CHS response to 2,4-dinitro-fluorobenezene. Analysis of the hapten-specific T cell pool demonstrates that priming of CD8+ T cells occurred normally in CD4- /- mice, as assessed by specific proliferative responses and interferon- (IFN-) production of purified CD8+ T cells. Furthermore, CD8+ T cells were able to adoptively transfer a normal CHS reaction. In contrast, total lymph node cells from CD4- /- mice showed decreased IFN- production and diminished specific cytotoxic T lymphocytes (CTL) activity, which could be reversed by in vitro restimulation with hapten-pulsed class II-deficient antigen-presenting cells. These data confirm that class I-restricted CD8+ T cells can fully develop in effectors of CHS in the absence of CD4+ T cell help and suggest that the impaired CHS in CD4- /- mice is because of the presence of a class II-restricted T cell subset, which controls CHS by inhibiting hapten-specific CTL responses.